University of Michigan
Ann Arbor, Michigan, 48109, United States
Location status: Recruiting
NCT Number: NCT06784895
The purpose of this randomized controlled study is to investigate the effect(s) of a pilot women-only cardiac rehabilitation (CR) program. The study team will be testing the effectiveness, compliance and enjoyment of this women's only cardiac rehabilitation (CR) program by comparing outcomes to those randomized to receive Michigan Medicine's current CR program (standard care), which includes people of all genders.
Study hypotheses:
* Women randomized to women-specific CR programming will have superior attendance and completion rates compared to women attending mixed-sex CR programming. * Women randomized to women-specific CR programming will experience greater improvement in clinical outcomes in comparison to those in mixed-sex CR programming.
Interested in participating?
Request Info40 year–80 year
Female
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Location status: Recruiting
This registration was updated on 11/24/2025 due to amendments that were approved at the IRBMED.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a 12-week program and will include 36 sessions 3 times a week. This group will also have Women-Only Education sessions. Participants will also have a 24-week follow-up visit from the time of entry.
Women-specific education content will be provided monthly in addition to the standard weekly "mini-teaches." This education content will be developed and delivered by experience health care professionals that are experts in women's health.
This is a 12-week program and will include up to 36 sessions 3 times a week. Participants will also have a 24-week follow-up visit from the time of entry. Exercise classes are medically supervised, and each program is individualized based upon medical history, cardiac risk factors, goals, and initial fitness level. Educational programs are arranged in a continuing series, with sessions taught by experts in nutrition therapy, stress reduction therapy, and exercise.
Time frame: 12 weeks (post CR)
CR completion rate defined as number of patients that "graduated" or completed CR programming versus the number of patients that started CR programming [i.e. attended 75% or more of the prescribed sessions (≥27 out of 36)], expressed as a percentage of participants per arm.
Time frame: 12 weeks (post CR)
Number of CR sessions attended out of number of CR sessions prescribed, expressed as a percentage
Time frame: 12 weeks (post CR)
Percentage of patients that have optimal BP control at program discharge, defined as systolic blood pressure (SBP) less than 130 mmHg and diastolic blood pressure (DBP) less than 80 Millimeters of mercury (mmHg).
Time frame: Baseline, 12 weeks (post CR)
Change in resting SBP from baseline to CR completion, measured using an automated blood pressure monitor and expressed in mmHg.
Time frame: Baseline, 12 weeks (post CR)
Change in resting DBP from baseline to CR completion, measured using an automated blood pressure monitor and expressed in mmHg.
Time frame: Baseline to 12 weeks (post CR)
Percentage (%) of patients with a positive depressive screen at CR entrance that experience a decrease in depressive symptoms (reduction in one or more levels of severity) as measured by changes in the Patient Health Questionnaire (PHQ)-9 score from baseline to completion of CR.
The PHQ-9 questionnaire is a self-assessed questionnaire that asks participants to respond to 9 questions with response options of 0, 1, 2 or 3. The total score scale ranges from 0 to 27. Higher scores indicate more symptoms of depression.
Time frame: Baseline to 12 weeks (post CR)
A change in PHQ-9 scores will be measured during the first 12 weeks of the study. The PHQ-9 questionnaire is a self-assessed questionnaire that asks participants to respond to 9 questions with response options of 0, 1, 2 or 3. The total score scale ranges from 0 to 27. Higher scores indicate more symptoms of depression.
Time frame: 12 weeks (post CR), 24 weeks
The PHQ-9 questionnaire is a self-assessed questionnaire that asks participants to respond to 9 questions with response options of 0, 1, 2 or 3. The total score scale ranges from 0 to 27. Higher scores indicate more symptoms of depression. A change in PHQ-9 scores will be measured during the first 12 weeks of the study and will be repeated 12 weeks following program completion.
Time frame: Baseline, up to 12 weeks (post CR)
Percentage of patients that achieve an increase in distance walked, in meters, by at least 10%, after participation in CR as measured by the 6-minute walk test (6MWT).
Time frame: Baseline, 12 weeks (post CR)
The distance walked in six minutes on a standard course will be measured in meters at baseline and CR Exit
Time frame: Baseline, 12 weeks (post CR)
Percentage of patients that display an overall mean increase in estimated METs (0.93 METs, 12.4%): with greatest increase occurring in "low" fitness patients < 5 METs (1.3 METs, 35% increase), followed by "moderate" fitness 5-8 METs (1.03 METs, 16% increase), and "high" fitness > 8 METs (0.77 METs, 8% increase)2,3 after participation in CR as measured by estimated exercise session peak METs.
Time frame: Baseline, up to 12 weeks (post CR)
The difference in estimated peak METs between baseline (defined as the third session to account for learning effect) and program completion.
Contact information is provided by the study sponsor or research team.
University of Michigan
Other
Designing and Assessing a Women Only Cardiac Rehabilitation Program
Acronym: CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06886789
Behavior, Body Weight
Providence, Rhode Island, United States
View Trial DetailsNCT06505109
Cardiac Rehabilitation, Cardiovascular Diseases
Eindhoven, North Brabant, Netherlands
View Trial DetailsNCT06244199
Cardiac Rehabilitation, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07721584
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details